Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase vs Alteplase in Acute Ischemic Stroke (AcT)
NCT03889249Phase 3Completed
- Sponsor
- University of Calgary
- Start
- Dec 2019
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by University of Calgary. Started Dec 2019; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03889249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03889249.